Anahita Dua, MD
Vascular Surgery · Boston, MANPI 1174848279
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Boston Scientific at 50.1% of the total. Reporting peaked in 2022 at $72,889 and has fallen 71.8% since, to $20,548 in 2025. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $561.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$93K
- Abbott$22K
- W. L. Gore & Associates, Inc.$14K
- Medtronic$12K
- Bard Peripheral Vascular, Inc.$10K
- Bolton Medical Inc$7K
- plus $27K from 31 others
Across 186 payments — averaging $12,002 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Haemonetics Corporation$1.8M
- Shockwave Medical, Inc$148K
- Inari Medical, Inc.$122K
- Bolton Medical Inc$87K
- Angiodynamics, Inc.$86K
- Atrium Medical Corporation$15K
- plus $1K from 1 others
What the payments were for
- Consulting fees$63,78934%
- Speaking & faculty fees$86,35046%
- Grants$6,2503%
- Travel & lodging$12,7047%
- Food & beverage$16,9079%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $93,167 |
| Abbott | 39 | $22,364 |
| W. L. Gore & Associates, Inc. | 42 | $13,817 |
| Medtronic(2 entities) | 26 | $11,898 |
| Bard Peripheral Vascular, Inc. | 18 | $10,030 |
| Bolton Medical Inc | 24 | $7,423 |
| Shockwave Medical, Inc | 6 | $4,838 |
| Angiodynamics, Inc. | 16 | $4,741 |
| Janssen Scientific Affairs, LLC | 4 | $4,162 |
| Cook Incorporated | 2 | $3,100 |
| Penumbra, Inc. | 3 | $1,505 |
| Teleflex LLC | 1 | $1,300 |
| Limflow Inc. | 4 | $1,135 |
| Inari Medical, Inc. | 10 | $1,063 |
| Terumo Medical Corporation | 8 | $863 |
| Cordis US CORP. | 3 | $553 |
| Heartflow, Inc. | 3 | $512 |
| Microvention, Inc. | 1 | $470 |
| Stryker | 6 | $466 |
| Silk Road Medical, Inc. | 5 | $432 |
| Philips North America LLC | 1 | $400 |
| Haemonetics Corporation | 4 | $385 |
| Endologix LLC | 2 | $207 |
| Integra Lifesciences Corporation | 2 | $180 |
| Smith+Nephew | 4 | $169 |
| Reflow Medical Inc | 1 | $156 |
| Artivion, Inc. | 1 | $149 |
| Johnson & Johnson | 4 | $114 |
| Cook Medical LLC | 3 | $99 |
| Kerecis Limited | 3 | $82 |
| Advanced Oxygen Therapy Inc. | 1 | $64 |
| Tactile Systems Technology Inc | 2 | $46 |
| Normatec Industries, LP | 1 | $34 |
| AbbVie | 1 | $31 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Viz.ai, Inc. | 1 | $22 |
| Asahi Intecc USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELUVIA$22,062
- GENERAL - THERAPIES$19,646
- OMNILINK ELITE$14,059
- GORE VIABAHN VBX Balloon Expandable Endo$10,257
- EKOSONIC$9,000
- Ranger$7,802
- Endurant$6,798
- GORE EXCLUDER AAA Endoprosthesis$4,845
- GORE TAG Thoracic Endoprosthesis$4,845
- GORE VIABAHN Endoprosthesis$4,845
- GORE EXCLUDER Iliac Branch Endoprosthesis$4,845
- OptiCross 35$4,800
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$4,675
- GORE VIABAHN Endoprosthesis with Heparin$4,275
- TREO ABDOMINAL STENT-GRAFT SYSTEM$4,263
- IN.PACT Admiral$4,058
- XARELTO$4,000
- ADVANCE$3,100
- AngioJet Ultra 5000A$2,825
- ANGIOJET$2,750
How this compares
$186,009 in reported general payments places this provider in the 95th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $269 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Boston
- Thomas OdonnellBoston$845K
- Marc SchermerhornBoston$71K
- Edwin GravereauxBoston$61K
- Christopher KwolekBoston$55K
- Shivani KumarBoston$45K
- Richard CambriaBoston$43K
- Payam SalehiBoston$40K
- Nicholas SwerdlowBoston$33K
- Mohamad HussainBoston$24K
- Stephanie TalutisBoston$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.